PP
Payal Paresh Bagadia
About Payal Paresh Bagadia
Data last updated:
Payal Paresh Bagadia is a Director at Apexio Pharma Private Limited (since 2023). The company operates in Paper. Apexio Pharma Private Limited reported revenue of ₹5.47 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Apexio Pharma Private Limited U21001MH2023PTC416041 | Director | 26 Dec 2023 | 2023 | ₹5.47 Cr (FY 2025) | Active |
Board colleagues of Payal Paresh Bagadia
| Name | DIN | Company | Designation |
|---|---|---|---|
| Aarti Rohitash Maheshwari | 09545278 | Apexio Pharma Private Limited | Director |
| Chenthanmara Kp Nair | 07346503 | Apexio Pharma Private Limited | Director |
| Paresh Shantilal Bagadia | 01636125 | Apexio Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Payal Paresh Bagadia
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Payal Paresh Bagadia
Payal Paresh Bagadia currently holds 1 directorship: Apexio Pharma Private Limited (Director, since 26 Dec 2023, revenue ₹5.47 Cr (FY 2025)).
Payal Paresh Bagadia was first appointed on 26 Dec 2023 as Director at Apexio Pharma Private Limited.
The current boards of Payal Paresh Bagadia's companies include Aarti Rohitash Maheshwari (Apexio Pharma Private Limited), Chenthanmara Kp Nair (Apexio Pharma Private Limited), Paresh Shantilal Bagadia (Apexio Pharma Private Limited).